Keywords: amevive, effective, psoriatic, arthritis, preliminary, results, ongoing
Amevive effective in psoriatic arthritis
Article | 28 February 2005
Preliminary results from an ongoing double-blind, placebo-controlled Phase II study involving 185 patients with active psoriatic arthritis indicate that Biogen Idec's ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Italy's pharma market slump set to continue, warns GlobalData
- Pfizer to split-off remaining 80% interest in Zoetis
